AMIX Autonomix Medical, Inc.
Fundamentals / CIK 0001617867 / USDAutonomix Medical, Inc. reported $0 in revenue and a net loss of $11.78M for the trailing twelve months ended September 30, 2026.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open AMIX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$0 Sep 30, 2026
-
Operating Income TTM-$12.03M Operating profit
-
Net Income TTM-$11.78M GAAP bottom line
-
Diluted EPS TTM-- Split-adjusted
-
Free Cash Flow TTM-$12.29M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$7.69M Total debt: --
Annual revenue and net income
4 fiscal years (2023 to 2026), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Mar 31 | Mar 31 | Mar 31 | Mar 31 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Research & Development | $7.14M | $4.72M | $2.23M | $745K |
| Total Operating Expenses | $17.03M | $11.59M | $12.03M | $1.99M |
| Operating Income | -$17.03M | -$11.59M | -$12.03M | -$1.99M |
| EBITDA | -$17.02M | -$11.40M | -$11.95M | -$1.99M |
| Interest Income | $319K | $354K | $127K | $0 |
| Interest Expense | $0 | $176K | $79K | $0 |
| Income Before Tax | -$16.71M | -$11.41M | -$15.43M | -$1.99M |
| Income Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$16.71M | -$11.41M | -$15.43M | -$1.99M |
| Basic EPS | -$2.33 | -$6.49 | -$229.76 | -$35.57 |
| Basic Shares Outstanding | 7.2M | 1.8M | 67.1K | 57.5K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $1.58M | $1.51M | $1.46M | $1.72M | $2.37M | $1.59M | $1.55M | $1.04M |
| Total Operating Expenses | $3.18M | $2.77M | $2.74M | $3.34M | $7.53M | $3.42M | $3.25M | $2.75M |
| Operating Income | -$3.18M | -$2.77M | -$2.74M | -$3.34M | -$7.53M | -$3.42M | -$3.25M | -$2.75M |
| EBITDA | -$3.17M | -$2.77M | -$2.73M | -$3.34M | -$7.53M | -$3.42M | -$3.07M | -$2.70M |
| Interest Income | $51K | $42K | $71K | $82K | $83K | $84K | $107K | $80K |
| Interest Expense | -- | -- | $0 | $0 | $0 | $0 | $46K | $45K |
| Income Before Tax | -$3.13M | -$2.73M | -$2.67M | -$3.26M | -$7.45M | -$3.34M | -$3.19M | -$2.71M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$3.13M | -$2.73M | -$2.67M | -$3.26M | -$7.45M | -$3.34M | -$11.41M | -$2.71M |
| Basic EPS | -$2.51 | -$5.02 | -- | -$0.36 | -$29.02 | -$22.69 | -- | -$1.47 |
| Basic Shares Outstanding | 1.2M | 543.7K | -- | 8.9M | 256.7K | 147.1K | -- | 1.8M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Mar 31 | Mar 31 | Mar 31 | Mar 31 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $7.00M | $9.14M | $8.61M | $865K |
| Cash & Short-Term Investments | $7.00M | $9.14M | $8.61M | $865K |
| Other Current Assets | $577K | $473K | $783K | $0 |
| Total Current Assets | $7.58M | $9.61M | $9.39M | $865K |
| Property, Plant & Equipment, Net | $19K | $21K | $16K | $0 |
| Total Non-Current Assets | $19K | $197K | $16K | $0 |
| Total Assets | $7.60M | $9.81M | $9.41M | $865K |
| Accounts Payable | $700K | $676K | $492K | $173K |
| Short-Term Debt | -- | -- | $0 | -- |
| Total Current Liabilities | $1.71M | $1.71M | $777K | $221K |
| Long-Term Debt | -- | -- | -- | $0 |
| Other Non-Current Liabilities | -- | -- | -- | $0 |
| Total Non-Current Liabilities | $0 | $0 | $1.00M | $0 |
| Total Liabilities | $1.71M | $1.71M | $1.78M | $221K |
| Total Debt (incl. Leases) | -- | -- | $0 | $0 |
| Common Stock | $1.0K | $2.0K | $1.0K | $12K |
| Retained Earnings | -$67.09M | -$50.38M | -$38.97M | -$23.54M |
| Total Stockholders' Equity | $5.89M | $8.10M | $7.63M | $644K |
| Total Equity | $5.89M | $8.10M | $7.63M | $644K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $7.69M | $3.46M | $7.00M | $9.93M | $7.48M | $8.59M | $9.14M | $11.82M |
| Cash & Short-Term Investments | $7.69M | $3.46M | $7.00M | $9.93M | $7.48M | $8.59M | $9.14M | $11.82M |
| Other Current Assets | $484K | $504K | $577K | $257K | $416K | $389K | $473K | $109K |
| Total Current Assets | $8.18M | $3.96M | $7.58M | $10.19M | $7.89M | $8.98M | $9.61M | $11.93M |
| Property, Plant & Equipment, Net | $19K | $16K | $19K | $20K | $16K | $19K | $21K | $20K |
| Total Non-Current Assets | $19K | $16K | $19K | $20K | $39K | $19K | $197K | $20K |
| Total Assets | $8.20M | $3.98M | $7.60M | $10.21M | $7.93M | $9.00M | $9.81M | $11.95M |
| Accounts Payable | $630K | $371K | $700K | $714K | $842K | $815K | $676K | $232K |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | -- | $1.13M |
| Total Current Liabilities | $1.25M | $818K | $1.71M | $1.65M | $1.49M | $1.97M | $1.71M | $2.25M |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1.25M | $818K | $1.71M | $1.65M | $1.49M | $1.97M | $1.71M | $2.25M |
| Total Debt (incl. Leases) | -- | -- | -- | -- | -- | -- | -- | $1.13M |
| Common Stock | $2.0K | $1.0K | $1.0K | $11K | $6.0K | $4.0K | $2.0K | $2.0K |
| Retained Earnings | -$72.95M | -$69.82M | -$67.09M | -$64.43M | -$61.17M | -$53.72M | -$50.38M | -$47.19M |
| Total Stockholders' Equity | $6.94M | $3.16M | $5.89M | $8.56M | $6.45M | $7.03M | $8.10M | $9.71M |
| Total Equity | $6.94M | $3.16M | $5.89M | $8.56M | $6.45M | $7.03M | $8.10M | $9.71M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Mar 31 | Mar 31 | Mar 31 | Mar 31 |
|---|---|---|---|---|
| Net Income | -$16.71M | -$11.41M | -$15.43M | -$1.99M |
| Depreciation & Amortization | $12K | $183K | $81K | $0 |
| Stock-Based Compensation | $529K | $1.63M | $618K | $0 |
| Change in Payables | $24K | $184K | $320K | $81K |
| Operating Cash Flow | -$12.28M | -$8.26M | -$6.60M | -$1.85M |
| Capital Expenditure | -$10K | -$14K | -$19K | $0 |
| Free Cash Flow | -$12.29M | -$8.27M | -$6.62M | -$1.85M |
| Investing Cash Flow | -$10K | -$14K | -$19K | $0 |
| Common Stock Issued | $0 | $2.0K | $2.84M | $675K |
| Financing Cash Flow | $10.16M | $8.80M | $14.41M | $675K |
| Net Change in Cash | -$2.13M | $528K | $7.74M | -$1.18M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$3.13M | -$2.73M | -$2.67M | -$3.26M | -$7.45M | -$3.34M | -$11.41M | -$2.71M |
| Depreciation & Amortization | $4.0K | $3.0K | $3.0K | $4.0K | $2.0K | $3.0K | $183K | $47K |
| Stock-Based Compensation | $53K | $2.0K | $1.0K | $2.0K | $138K | $388K | $1.63M | $418K |
| Change in Payables | $176K | -$329K | $22K | -$164K | $26K | $140K | $184K | -$342K |
| Operating Cash Flow | -$2.61M | -$3.54M | -$2.89M | -$2.97M | -$3.82M | -$2.60M | -$8.26M | -$2.30M |
| Capital Expenditure | -- | -- | -$3.0K | -$7.0K | $0 | $0 | -$14K | -$5.0K |
| Free Cash Flow | -- | -- | -$2.90M | -$2.98M | -$3.82M | -$2.60M | -$8.27M | -$2.31M |
| Investing Cash Flow | -- | -- | -$3.0K | -$7.0K | $0 | $0 | -$14K | -$5.0K |
| Common Stock Issued | -- | $0 | -- | -- | -- | $2.12M | $2.0K | $0 |
| Financing Cash Flow | $6.85M | $0 | -$35K | $5.43M | $2.71M | $2.06M | $8.80M | $8.97M |
| Net Change in Cash | $4.23M | -$3.54M | -$2.93M | $2.46M | -$1.11M | -$547K | $528K | $6.67M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Mar 31 | Mar 31 | Mar 31 | Mar 31 |
|---|---|---|---|---|
| Return on Equity (ROE) | -283.5% | -140.9% | -202.2% | -309.0% |
| Return on Assets (ROA) | -219.9% | -116.4% | -164.0% | -230.1% |
| Current Ratio | 4.45x | 5.63x | 12.09x | 3.91x |
| Quick Ratio | 4.11x | 5.35x | 11.08x | 3.91x |
| Debt to Equity | -- | -- | 0.00x | 0.00x |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -169.7% | -509.4% | -283.5% | -297.4% | -386.5% | -288.2% | -242.4% | -243.6% |
| Return on Assets (ROA) | -143.8% | -404.7% | -219.9% | -249.3% | -314.0% | -225.3% | -200.2% | -197.8% |
| Current Ratio | 6.52x | 4.85x | 4.45x | 6.18x | 5.31x | 4.57x | 5.63x | 5.31x |
| Quick Ratio | 6.13x | 4.23x | 4.11x | 6.02x | 5.03x | 4.37x | 5.35x | 5.27x |
| Debt to Equity | -- | -- | -- | -- | -- | -- | -- | 0.12x |